You can buy or sell NGM and other stocks, options, ETFs, and crypto commission-free!
NGM Biopharmaceuticals, Inc. engages in the discovery and development of therapeutics for major diseases with an initial focus on cardio-metabolic and liver diseases. Its portfolio if composed of product candidates which focuses on non-alcoholic steatohepatitis, type 2 diabetes, obesity, oncology and age-related macular degeneration. Read More The company was founded by Jin-Long Chen in 2008 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
-$0.17 per share